AVR 0.08% $12.19 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-249

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,338 Posts.
    lightbulb Created with Sketch. 58
    Further to that point - Actually IMHO, the "presence" of skin in the game can also influence how directors make decisions on the raising of capital.

    It's all to do with how *much* "skin"

    To little- don't really care how it's done. Just get the capital.
    To much - care a lot. As in "do I actually have the personal financial capacity *myself* to support it?"

    All IMHO. Go Admedus. GLTAH. I wish you well.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.